LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Biotech is a key driver for a strong and united Europe

12/02/2025

PRESS RELEASE

Brussels, 12 February 2025

EuropaBio welcomes the European Commission Work Programme 2025 “Moving forward together: A Bolder, Simpler, Faster Union” published yesterday. Biotech innovation is an important milestone towards competitiveness delivering prosperity, resilience, and leadership for the EU.

We welcome wider initiatives announced that will contribute to strengthening the EU innovation ecosystem, including the Bioeconomy strategy, the Clean Industrial Deal, the Industrial Decarbonisation Act and the EU Start up and Scale Up Strategy. EuropaBio looks forward to supporting ambitious policy and legislative interventions for a competitive, innovative, and sustainable Europe. We look towards 2026 for an ambitious EU Biotech Act to unlock Faster Financing, deliver a Simpler EU, and be Stronger Together by fully unleashing the biotech revolution across sectors.

Dr. Claire Skentelbery, Director General of EuropaBio commented “The Work Programme demonstrates that the EU can mobilise its incredible depth of scientific innovation with an eye to impact. It gives us an excellent pathway to follow with our ecosystem partners for the delivery of biotechnology across sectors.”

Biotech is a key driver for a strong and united Europe


Download
Share
Adrian Lincoln
Adrian Lincoln

Related posts

31/10/2025

Healthcare Associations warn of risks from PFAS restriction approach  – failure to assess the impact on the availability of human and animal medicines


Read more
02/10/2025

Public Consultation Response to the European Innovation Act proposal


Read more
30/09/2025

Public Consultation Response to the European Commission’s 28th Regime proposal


Read more

Important links

  • Healthcare Associations warn of risks from PFAS restriction approach  – failure to assess the impact on the availability of human and animal medicines
  • Public Consultation Response to the European Innovation Act proposal

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.